Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
종목 코드 LFCR
회사 이름Lifecore Biomedical Inc
상장일Feb 15, 1996
CEOMr. Paul Josephs
직원 수406
유형Ordinary Share
회계 연도 종료Feb 15
주소3515 Lyman Boulevard
도시CHASKA
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호55318
전화19523684300
웹사이트https://www.lifecore.com/
종목 코드 LFCR
상장일Feb 15, 1996
CEOMr. Paul Josephs
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음